Communication Dans Un Congrès Année : 2022

The Role of Massive Databases in the Post-market Clinical Follow-up of Medical Devices

Résumé

With the application of new European regulations on medical devices in May 2021, the requirements for clinical evaluation have been strongly reinforced. Post-marketing clinical follow-up is now a key activity for manufacturers to keep their medical devices on the market. The use of material-epidemiology studies and real-life databases has multiple strengths and advantages. However, the weaknesses and limitations identified do not yet allow manufacturers (especially small and medium-sized companies) to fully utilize these tools for post-market clinical follow-up. Yet certain technological and regulatory developments already implemented, and to be implemented over time, suggest that these tools could play a crucial role in the clinical monitoring of medical devices in the future. In order to better define the future use of real-life data in post-market clinical follow-up activities, a comprehensive update of technological and regulatory surveillance is still required.

Fichier principal
Vignette du fichier
109526.pdf (390.84 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-03656831 , version 1 (11-05-2022)

Licence

Identifiants

Citer

Marion Burland, Thierry Chevallier. The Role of Massive Databases in the Post-market Clinical Follow-up of Medical Devices. Proceedings of the 15th International Joint Conference on Biomedical Engineering Systems and Technologies - ClinMed. Special Session on Dealing with the Change in European Regulations for Medical Devices, Feb 2022, Vienna, Austria. pp.243-249, ⟨10.5220/0010952600003123⟩. ⟨hal-03656831⟩
136 Consultations
251 Téléchargements

Altmetric

Partager

  • More